Samuel K. Kulp, D.V.M., Ph.D.
Affiliations: | 2001 | Veterinary Biosciences | Ohio State University, Columbus, Columbus, OH |
2002-2017 | Medicinal Chemistry | Ohio State University, Columbus, Columbus, OH | |
2018- | Pharmaceutics and Pharmaceutical Chemistry | Ohio State University, Columbus, Columbus, OH |
Google:
"Samuel Kulp"Mean distance: (not calculated yet)
Parents
Sign in to add mentorYoung C. Lin | grad student | 2001 | Ohio State | |
(Characterization of a larval tapeworm excretory -secretory product that inhibits steroidogenesis.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Liva SG, Tseng YC, Dauki AM, et al. (2020) Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor. Embo Molecular Medicine. e9910 |
Lu C, Yang D, Klement JD, et al. (2020) Abstract A32: The SUV39H1-H3K9me3 pathway represses cytotoxic T lymphocyte effector expression to confer colon carcinoma immune escape Cancer Immunology Research. 8 |
Weng SC, Kashida Y, Kulp SK, et al. (2019) Retraction: Sensitizing Estrogen Receptor-negative Breast Cancer Cells to Tamoxifen with OSU-03012, a Novel Celecoxib-derived Phosphoinositide-dependent Protein Kinase-1/Akt Signaling Inhibitor. Molecular Cancer Therapeutics. 18: 869 |
Lu C, Yang D, Klement JD, et al. (2019) SUV39H1 represses the expression of cytotoxic T-lymphocyte effector genes to promote colon tumor immune evasion. Cancer Immunology Research |
Murahari S, Jalkanen AL, Kulp SK, et al. (2017) Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis. Bmc Cancer. 17: 67 |
Wu H, Yang M, Chu P, et al. (2017) Abstract 1360: Novel function of p21-activated kinase 3 (PAK3) in regulating Akt phosphorylation and pancreatic cancer stem cell phenotypes Cancer Research. 77: 1360-1360 |
Chu PC, Kulp SK, Bekaii-Saab T, et al. (2016) Targeting integrin-linked kinase to suppress oncogenic KRAS signaling in pancreatic cancer. Small Gtpases. 1-5 |
Henderson SE, Ding LY, Mo X, et al. (2016) Suppression of Tumor Growth and Muscle Wasting in a Transgenic Mouse Model of Pancreatic Cancer by the Novel Histone Deacetylase Inhibitor AR-42. Neoplasia (New York, N.Y.). 18: 765-774 |
Himmel LE, Lustberg MB, DeVries AC, et al. (2016) Minocycline, a putative neuroprotectant, co-administered with doxorubicin-cyclophosphamide chemotherapy in a xenograft model of triple-negative breast cancer. Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie |
Hsu EC, Kulp SK, Huang HL, et al. (2016) Integrin-linked kinase as a novel molecular switch of the IL-6-NF-κB signaling loop in breast cancer. Carcinogenesis |